Centurion Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.1M Sell
1,750
-138
-7% -$141K 0.5% 51
2026
Q1
$1.74M Sell
1,888
-50
-3% -$50.7K 0.39% 67
2025
Q4
$2.08M Sell
1,938
-40
-2% -$38.2K 0.46% 55
2025
Q3
$1.51M Buy
1,978
+1,050
+113% +$781K 0.34% 66
2025
Q2
$723K Sell
928
-52
-5% -$40.4K 0.21% 86
2025
Q1
$757K Hold
980
0.24% 74
2024
Q4
$757K Buy
980
+5
+0.5% +$4.14K 0.24% 74
2024
Q3
$864K Buy
+975
New +$877K 0.28% 69
2024
Q1
$970K Buy
1,247
+306
+33% +$218K 0.38% 51
2023
Q4
$549K Hold
941
0.23% 73
2023
Q3
$505K Hold
941
0.25% 71
2023
Q2
$441K Sell
941
-1
-0.1% -$419 0.21% 84
2023
Q1
$324K Sell
942
-1
-0.1% -$337 0.16% 103
2022
Q4
$345K Buy
+943
New +$334K 0.19% 100

Other funds holding LLY

Centurion Wealth Management's LLY Position: Q2 2026 in Review

Centurion Wealth Management reduced its Eli Lilly (LLY) stake by 7.3% in Q2 2026, selling an estimated $141K and leaving 1,750 shares worth $2.1M. The position accounts for 0.5% of the portfolio, ranked #51.

Centurion Wealth Management first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Centurion Wealth Management held 1,750 shares of Eli Lilly worth $2.1M as of Q2 2026.
  • Centurion Wealth Management sold 138 Eli Lilly shares in Q2 2026, an estimated $141K.
  • Eli Lilly made up 0.5% of Centurion Wealth Management's portfolio in Q2 2026, its #51 holding.
  • Centurion Wealth Management first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Centurion Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.